Researcher.Life Logo

HEPATIC ONCOLOGY : Impact Factor & More

eISSN: 2045-0931pISSN: 2045-0923
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on HEPATIC ONCOLOGY

HEPATIC ONCOLOGY Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher FUTURE MEDICINE LTD
Language English
Frequency Quarterly
Article Processing ChargesUSD 1415
Publication Time13
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2014
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 13
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY-NC-ND
OA statementVisit website
View less

Planning to publish in HEPATIC ONCOLOGY ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in HEPATIC ONCOLOGY

Clinical management of liver cancer patients with immune checkpoint inhibitors treatment
  • 30 Oct 2025
  • Hepatic Oncology
Qualitative research to understand the patient experience with advanced and/or metastatic hepatocellular carcinoma
  • 23 Oct 2025
  • Hepatic Oncology
Two-way increased-risk associations between hepatobiliary cancers and other malignancies: a population-based study
  • 16 Oct 2025
  • Hepatic Oncology
Management of hepatocellular carcinoma prior to liver transplantation: latest developments.
  • 23 Aug 2025
  • Hepatic oncology
Real-world treatment patterns and outcomes in patients with early-stage HCC in the US treated with resection or ablation.
  • 24 Jul 2025
  • Hepatic oncology
Hepatic arterial infusion chemotherapy in patients with unresectble hepatocellular carcinoma: 3-year survival update
  • 17 Jun 2025
  • Hepatic Oncology
Clinical management of liver cancer patients with immune checkpoint inhibitors treatment
  • 30 Oct 2025
  • Hepatic Oncology
Qualitative research to understand the patient experience with advanced and/or metastatic hepatocellular carcinoma
  • 23 Oct 2025
  • Hepatic Oncology
Two-way increased-risk associations between hepatobiliary cancers and other malignancies: a population-based study
  • 16 Oct 2025
  • Hepatic Oncology
Management of hepatocellular carcinoma prior to liver transplantation: latest developments.
  • 23 Aug 2025
  • Hepatic oncology
Real-world treatment patterns and outcomes in patients with early-stage HCC in the US treated with resection or ablation.
  • 24 Jul 2025
  • Hepatic oncology
Hepatic arterial infusion chemotherapy in patients with unresectble hepatocellular carcinoma: 3-year survival update
  • 17 Jun 2025
  • Hepatic Oncology

FAQs on HEPATIC ONCOLOGY